Quality of Life in Patients with Noninfectious Uveitis Treated with or without Systemic Anti-inflammatory Therapy

References

• de Smet MD, Taylor SRJ, Bodaghi B, et al. Understanding uveitis: the impact of research on visual outcomes. Prog Retin Eye Res. 2011;30:452–470
   PubMed Web of Science ®Google Scholar
• Durrani OM, Meads CA, Murray PI. Uveitis: a potentially blinding disease. Ophthalmologica. 2004;218:223–236
   PubMed Web of Science ®Google Scholar
• Nguyen QD, Hatef E, Kayen B, et al. A cross-sectional study of the current treatment patterns in noninfectious uveitis among specialists in the United States. Ophthalmology. 2011;118:184–190
   PubMed Web of Science ®Google Scholar
• Bradley EA, Bradley D, Bartley GB. Evaluating health-related quality of life in ophthalmic disease—practical considerations. Arch Ophthalmol. 2006;124:121–122
   PubMedGoogle Scholar
• Miserocchi E, Modorati G, Mosconi P, et al. Quality of life in patients with uveitis on chronic systemic immunosuppressive treatment. Ocul Immunol Inflamm. 2010;18:297–304
   PubMed Web of Science ®Google Scholar
• Cole SR, Beck RW, Moke PS, et al. The National Eye Institute Visual Function Questionnaire: experience of the ONTT. Optic Neuritis Treatment Trial. Invest Ophthalmol Vis Sci. 2000;41:1017–1021
   PubMed Web of Science ®Google Scholar
• Gutierrez P, Wilson MR, Johnson C, et al. Influence of glaucomatous visual field loss on health-related quality of life. Arch Ophthalmol. 1997;115:777–784
   PubMed Web of Science ®Google Scholar
• Linder M, Chang TS, Scott IU, et al. Validity of the visual function index (VF-14) in patients with retinal disease. Arch Ophthalmol. 1999;117:1611–1616
   PubMed Web of Science ®Google Scholar
• Mangione CM, Gutierrez PR, Lowe G, et al. Influence of age-related maculopathy on visual functioning and health-related quality of life. Am J Ophthalmol. 1999;128:45–53
   PubMed Web of Science ®Google Scholar
• Jalil A, Yin K, Coyle L, et al. Vision-related quality of life and employment status in patients with uveitis of working age: a prospective study. Ocul Immunol Inflamm. 2012;20:262–265
   PubMed Web of Science ®Google Scholar
• Murphy CC, Greiner K, Plskova J, et al. Validity of using vision-related quality of life as a treatment end point in intermediate and posterior uveitis. Br J Ophthalmol. 2007;91:154–156
   PubMed Web of Science ®Google Scholar
• Murphy CC, Hughes EH, Frost NA, Dick AD. Quality of life and visual function in patients with intermediate uveitis. Br J Ophthalmol. 2005;89:1161–1165
   PubMed Web of Science ®Google Scholar
• Onal S, Savar F, Akman M, Kazokoglu H. Vision- and health-related quality of life in patients with Behçet uveitis. Arch Ophthalmol. 2010;128:1265–1271
   PubMedGoogle Scholar
• Schiffman RM, Jacobsen G, Whitcup SM. Visual functioning and general health status in patients with uveitis. Arch Ophthalmol. 2001;119:841–849
   PubMed Web of Science ®Google Scholar
• Stanbury RM, Graham EM. Systemic corticosteroid therapy—side effects and their management. Br J Ophthalmol. 1998;82:704–708
   PubMed Web of Science ®Google Scholar
• Min DI, Monaco AP. Complications associated with immunosuppressive therapy and their management. Pharmacotherapy. 1991;11:S119–S125
   Web of Science ®Google Scholar
• Menezo V, Lau C, Comer M, Lightman S. Clinical outcome of chronic immunosuppression in patients with non-infectious uveitis. Clin Exp Ophthalmol. 2005;33:16–21
   PubMed Web of Science ®Google Scholar
• Multicenter Uveitis Steroid Treatment (MUST) Trial Research Group, Kempen JH, Altaweel MM, et al. Randomized comparison of systemic anti-inflammatory therapy versus fluocinolone acetonide implant for intermediate, posterior, and panuveitis: the multicenter uveitis steroid treatment trial. Ophthalmology. 2011;118:1916–1926
   PubMed Web of Science ®Google Scholar
• Jabs DA, Nussenblatt RB, Rosenbaum JT, Standardization of Uveitis Nomenclature (SUN) Working Group. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol. 2005;140:509–516
   PubMed Web of Science ®Google Scholar
• Lange C, Feltgen N, Junker B, et al. Resolving the clinical acuity categories "hand motion" and "counting fingers" using Freiburg Visual Acuity Test (FrACT). Graef Arch Clin and Exp. 2009;247:137–142
   PubMed Web of Science ®Google Scholar
• Holladay JT. Proper method for calculation average visual acuity. J Refract Surg. 1997;13:388–391
   PubMed Web of Science ®Google Scholar
• Mangione CM, Lee PP, Gutierrez PR, et al. Development of the 25-Item National Eye Institute Visual Function Questionnaire. Arch Ophthalmol. 2001;119:1050–1058
   PubMed Web of Science ®Google Scholar
• Ware JE, Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34:220–233
   PubMed Web of Science ®Google Scholar
• Tan P, Koh YT, Wong PY, Teoh SC. Evaluation of the impact of uveitis on visual-related quality of life. Ocul Immunol Inflamm. 2012;20:453–459
   PubMed Web of Science ®Google Scholar
• Frick KD, Drye LT, Kempen JH, et al. Associations among visual acuity and vision- and health-related quality of life among patients in the multicenter uveitis steroid treatment trial. Invest Ophthalmol Vis Sci. 2012;53:1169–1176
   PubMed Web of Science ®Google Scholar
• Naik RK, Rentz AM, Foster CS, et al. Normative comparison of patient-reported outcomes in patients with noninfectious uveitis. JAMA Ophthalmol. 2013;131:219–225
   PubMed Web of Science ®Google Scholar
• Siddique SS, Shah R, Suelves AM, Foster CS. Road to remission: a comprehensive review of therapy in uveitis. Expert Opin Inv Drug. 2011;20:1497–1515
   PubMed Web of Science ®Google Scholar
• Oertelt-Prigione S. The influence of sex and gender on the immune response. Autoimmun Rev. 2012;11:A479–A485
   PubMed Web of Science ®Google Scholar
• Quintero OL, Amador-Patarroyo MJ, Montoya-Ortiz G, et al. Autoimmune disease and gender: plausible mechanisms for the female predominance of autoimmunity. J Autoimmun. 2012;38:J109–J119
   PubMed Web of Science ®Google Scholar
• Durrani OM, Tehrani NN, Marr JE, et al. Degree, duration, and causes of visual loss in uveitis. Br J Ophthalmol. 2004;88:1159–1162
   PubMed Web of Science ®Google Scholar
• Maca SM, Schiesser AW, Sobala A, et al. Distress, depression and coping in HLA-B27-associated anterior uveitis with focus on gender differences. Br J Ophthalmol. 2011;95:699–704
   PubMed Web of Science ®Google Scholar